Age trends of internalizing and externalizing problems in children with neurofibromatosis type 1: a multicenter study
摘要
Children with neurofibromatosis type 1 (NF1) frequently experience internalizing and externalizing problems, yet their developmental patterns remain poorly understood. This study examined age-related trends and subgroup differences in these symptoms.
MethodsIntegrative data analysis combined 1,841 observations from 1,194 children with NF1 (ages 3–18) across nine institutions. Internalizing/externalizing problems were assessed using parent-rated Child Behavior Checklist (CBCL sample; n = 1,087 observations) or Behavior Assessment System for Children (BASC sample; n = 754 observations). The two samples were analyzed separately. Time-varying effect modeling characterized age-related symptom patterns overall and across subgroups defined by sex, NF1 inheritance mode, the presence of plexiform neurofibromas, and attention-deficit/hyperactivity disorder (ADHD) diagnosis.
ResultsAcross both assessments, children with NF1 exhibited greater internalizing and externalizing problems relative to normative means, although mean scores generally remained below clinical thresholds. Deviations were greater in older than younger children for internalizing problems, whereas deviations in externalizing symptoms remained relatively similar across age. Age patterns for both problems were largely consistent across subgroups except that children with ADHD showed higher symptom levels and distinct age patterns.
ConclusionsFindings highlight age-related differences in behavioral symptoms in NF1 relative to population norms, with greater internalizing deviations and relatively consistent externalizing deviations across age, as well as more pronounced deviations among children with co-occurring ADHD. Although interpretation is limited by reliance on parent reports, cross-sectional data, and normative rather than control comparisons, findings underscore the importance of ongoing monitoring and future longitudinal, multi-informant research to clarify developmental trajectories and clinical needs in NF1.